Effects of nicotine and vitamin E on glucose 6-phosphate dehydrogenase activity in some rat tissuesin vivoandin vitro

Abstract

Effects of nicotine, and nicotine + vitamin E on glucose 6-phosphate dehydrogenase (G-6PD) activity in rat muscle, heart, lungs, testicle, kidney, stomach, brain and liver were investigated in vivo and in vitro on partially purified homogenates. Supplementation period was 3 weeks (n = 8 rats per group): nicotine [0.5 mg/kg/day, intraperitoneal (ip)]; nicotine + vitamin E [75 mg/kg/day, intragastric (ig)]; and control group (receiving only vehicle). The results showed that nicotine (0.5 mg/kg, ip) inhibited G-6PD activity in the lungs, testicle, kidney, stomach and brain by 12.5% (p < 0.001), 48% (p < 0.001), 20.8% (p < 0.001), 13% (p < 0.001) and 23.35% (p < 0.001) respectively, and nicotine had no effects on the muscle, heart and liver G6PD activity. Also, nicotine + vitamin E inhibited G-6PD activity in the testicle, brain, and liver by 32.5% (p < 0.001), 21.5% (p < 0.001), and 16.5% (p < 0.001) respectively, and nicotine + vitamin E activated the muscle, and stomach G-6PD activity by 36% (p < 0.05), and 20% (p < 0.001) respectively. In addition, nicotine + vitamin E did not have any effects on the heart, lungs, and kidney G-6PD activity. In addition, in vitro studies were also carried out to elucidate the effects of nicotine and vitamin E on G-6PD activity, which correlated well with in vivo experimental results in lungs, testicles, kidney, stomach, brain and liver tissues. These results show that vitamin E administration generally restores the inactivation of G-6PD activity due to nicotine administration in various rat tissues in vivo, and also in vitro.

Polydatin, a Herbal Bioflavonoid, Is Protective Against Cerebral Ischemia-Reperfusion Injury: Molecular, Biochemical and Histological Data

“…This color was measured spectrophotometrically at 532 nm. MDA concentrations were calculated with the aid of the standard table of the MDA-TBA complex [39][40][41][42].…”

The in vitro effect of 5-FU and Tamoxifen Chemotherapeutics on penthose phosphate pathway enzymes

“…The results of this study showed that nicotine inhibited the G6PD activity in the lungs, testicle, kidney, stomach and brain tissues. Vitamin E administration, on the other hand, regulated the G6PD activity, which was inhibited by nicotine administration in various rat tissues both in vivo and in vitro [37]. Temel et al investigated the in vivo and in vitro effects of astaxanthin, which is natural antioxidants, and aluminum ions on G6PD and 6PGD enzyme activities.…”

Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?

“…Apart from the elevated oxidative stress, G6PD-deficient cells are at a greater risk for protein glycosylation (4), a process that plays an essential role in viral pathogenesiseincluding COVID-19e by promoting folding, trafficking and viral spread, whilst host cell and viral glycans are known to act as attachment factors (5,6). Notably, a previous study has shown that nicotine significantly inhibited G6PD activity in the rat lung, while the potent anti-oxidant vitamin E was able to restore this effect (7).…”